Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Operating Expenses (2019 - 2026)

Immatics (IMTX) posted Operating Expenses of $1.4 billion for Q4 2025, up 2119.8% sequentially from -$70.0 million in Q3 2025, and up 305.06% YoY from $348.9 million in Q4 2024.

Analysis

Immatics (IMTX) Operating Expenses (2019 - 2026) Analysis & Trends

Immatics has reported Operating Expenses for 7 years, with the latest figure at $1.4 billion in Q4 2025.

  • Quarterly Operating Expenses rose 305.06% year-over-year to $1.4 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 billion (up 245.26% YoY) and the FY2025 annual result came in at $1.2 billion, up 238.77% from the prior year.
  • Operating Expenses improved to $1.4 billion in Q4 2025 per IMTX's latest filing, from -$70.0 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $1.4 billion in Q4 2025 and troughed at -$689.2 million in Q4 2024.
  • A 5-year average of $108.9 million and a median of -$39.3 million in 2022 frame the typical range for Operating Expenses.
  • The sharpest annual moves came in 2021 and 2024: Operating Expenses jumped 1832.07% in 2021, then tumbled 182.17% in 2024.
  • Over 5 years, Operating Expenses stood at $610.2 million in 2021, then climbed by 13.13% to $690.3 million in 2022, then climbed by 21.5% to $838.7 million in 2023, then plunged by 182.17% to -$689.2 million in 2024, then surged by 305.06% to $1.4 billion in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods registered $1.4 billion, -$70.0 million, and -$65.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 2.09 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 3.00 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -1.05 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 960.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 505.13 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.21 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.06 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 541.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 427.03 Mn
10 Immatics 1.17 Bn 711.21 Mn - -88.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -88.74 Mn
Mar 31, 2026 -86.28 Mn
Dec 31, 2025 -73.69 Mn
Sep 30, 2025 -69.97 Mn
Jun 30, 2025 -65.52 Mn
Mar 31, 2025 -56.78 Mn
Dec 31, 2024 -59.17 Mn
Sep 30, 2024 -54.98 Mn
Jun 30, 2024 -48.83 Mn
Mar 31, 2024 -47.53 Mn
Dec 31, 2023 -46.95 Mn
Sep 30, 2023 -42.87 Mn
Jun 30, 2023 -39.94 Mn
Mar 31, 2023 -39.89 Mn
Dec 31, 2022 -38.35 Mn
Sep 30, 2022 -37.30 Mn
Jun 30, 2022 -36.17 Mn
Mar 31, 2022 -38.63 Mn
Dec 31, 2021 -36.38 Mn
Sep 30, 2021 -34.78 Mn